Top Abstract Purchase Related
Home
>
Node
>
Subnode

Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women

Murphy, A.; Cropp, C.S.; Smith, B.S.; Burkman, R.T.; Zacur, H.A.

Fertility and Sterility 53(1): 35-39

1990

ISSN/ISBN: 0015-0282
PMID: 2136834
Document Number: 556537
The effectiveness of a low-dose oral contraceptive (OC) in suppressing plasma levels of gonadotropins, ovarian, and adrenal androgens and stimulating sex hormone-binding globulin (SHBG) was evaluated prospectively in nonhirsute women. Thirty-three women ingested 35 micrograms of ethinyl estradiol and 1 mg of norethindrone beginning within day 1 to 5 of the menstrual cycle. Baseline levels of luteinizing hormone, follicle-stimulating hormone, total testosterone (T), androstenedione (A), dehydroepiandrosterone sulfate (DHEAS), and SHBG were obtained before ingestion of the OC and repeated after 3, 6 and, 9 months of OC use on day 1 to 5 of the OC "cycle". A significant suppression of gonadotropin levels is seen in nonhirsute women. Sex hormone binding globulin is consistently stimulated by the low-dose OC. A significant suppression of T and DHEAS is observed. No change was seen in levels of A. The demonstrated effects become evident at 3 months and are maintained at 6 and 9 months.

Document emailed within 1 workday
Secure & encrypted payments

Yoshino, K.; Takahashi, K.; Eda, Y.; Okada, S.; Kitao, M. 1993: Plasma androgens and sex hormone binding globulin in women with polycystic ovaries diagnosed by transvaginal ultrasound Journal of Reproductive Medicine 38(11): 858-862
Sobbrio, G.A.; Granata, A.; Granese, D.; D'Arrigo, F.; Panacea, A.; Nicita, R.; Pullè, C.; Trimarchi, F. 1991: Sex hormone binding globulin, cortisol binding globulin, thyroxine binding globulin, ceruloplasmin: changes in treatment with two oral contraceptives low in oestrogen Clinical and Experimental Obstetrics and Gynecology 18(1): 43-45
Odlind, V.; Milsom, I.; Persson, I.; Victor, A. 2002: Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstetricia et Gynecologica Scandinavica 81(6): 482-490
Abdalla, K.A.; Shabaan, M.M.; Stanczyk, F.Z. 1992: Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets Contraception 45(2): 111-118
Lapidus, L.; Lindstedt, G.; Lundberg, P.A.; Bengtsson, C.; Gredmark, T. 1986: Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women Clinical Chemistry 32(1 Part 1): 146-152
Jeppsson, S.; Gershagen, S.; Johansson, E. D. B.; Rannevik, G. 1982: Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera(R)) as a contraceptive agent European Journal of Endocrinology 99(3): 339-343
Scholes, D.; Hubbard, R.A.; Ichikawa, L.E.; LaCroix, A.Z.; Spangler, L.; Beasley, J.M.; Reed, S.; Ott, S.M. 2011: Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation Journal of Clinical Endocrinology and Metabolism 96(9): E1380-E1387
Georgala, G.; Papasotiriou, V.; Stavropoulos, P. 1986: Serum testosterone and sex hormone binding globulin levels in women with androgenetic alopecia Acta Dermato-Venereologica 66(6): 532-534
Kuhnz, W.; al-Yacoub, G.; Fuhrmeister, A. 1992: Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation Contraception 46(5): 455-469
Palatsi, R.; Hirvensalo, E.; Liukko, P.; Malmiharju, T.; Mattila, L.; Riihiluoma, P.; Ylöstalo, P. 1984: Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives Acta Dermato-Venereologica 64(6): 517-523
Bancroft, J.; Sherwin, B.B.; Alexander, G.M.; Davidson, D.W.; Walker, A. 1991: Oral contraceptives, androgens, and the sexuality of young women: I. a comparison of sexual experience, sexual attitudes, and gender role in oral contraceptive users and nonusers Archives of Sexual Behavior 20(2): 105-120
Hagstad, A.; Damber, J.E.; Janson, P.O.; Samsioe, G.; Södergård, R. 1984: Effects of two estradiol/norgestrel combinations on the ovulatory pattern and on sex hormone binding globulin capacity in women around forty years of age Acta Obstetricia et Gynecologica Scandinavica 63(4): 321-324
Bancroft, J.; Sherwin, B.B.; Alexander, G.M.; Davidson, D.W.; Walker, A. 1991: Oral contraceptives, androgens, and the sexuality of young women: II. the role of androgens Archives of Sexual Behavior 20(2): 121-135
Bakas, P.; Hassiakos, D.; Grigoriadis, C.; Vlahos, N.F.; Liapis, A.; Creatsas, G. 2014: Effect of a low dose combined oral contraceptive pill on the hormonal profile and cycle outcome following COS with a GnRH antagonist protocol in women over 35 years old Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 30(11): 825-829
O'Connell, K.J.; Osborne, L.M.; Westhoff, C. 2005: Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive Contraception 72(5): 323-327
Leinonen, P.; Hammond, G.L.; Lukkarinen, O.; Vihko, R. 1979: Serum sex hormone binding globulin and testosterone binding after estradiol administration, castration, and their combination in men with prostatic carcinoma Investigative Urology 17(1): 24-27
Matsushima, T.; Akira, S.; Asakura, H.; Takeshita, T. 2017: Low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for successful long-term management of adenomyosis associated with cerebral venous and sinus thrombosis from low-dose oral contraceptive use Clinical and Experimental Obstetrics and Gynecology 44(1): 143-145
Potin, V.V.; Svechnikova, F.A.; Khrustaleva, G.F.; Chembartseva, A.V. 1979: Reaction of the ovaries to endogenous gonadotropins in women after single administration of releasing hormone stimulating the secretion of luteinizing hormone Akusherstvo i Ginekologiia 5: 13-15
Cetin, N.N.; Karabacak, O.; Korucuoglu, U.; Karabacak, N. 2009: Gonadotropin-releasing hormone analog combined with a low-dose oral contraceptive to treat heavy menstrual bleeding International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 104(3): 236-239
Swinkels, L.M.; van Hoof, H.J.; Ross, H.A.; Smals, A.G.; Benraad, T.J. 1991: Concentrations of salivary testosterone and plasma total, non-sex-hormone-binding globulin-bound, and free testosterone in normal and hirsute women during administration of dexamethasone/synthetic corticotropin Clinical Chemistry 37(2): 180-185